As of 2:30 PM on the 1st, SK is trading at 214,500 KRW, up 0.23% from the previous day. The trading volume is 154,435 shares, which is about 32.01% of the previous day's volume. SK is known as the holding company of the SK Group.


On August 31, Shim Wonseop, a researcher at Cape Investment & Securities, stated, "The company's stock price has adjusted by about 30% and is now in a sideways range due to 1) the momentum loss following the listing of SK Biopharm, and 2) poor performance of SK Innovation and SK E&S in 2Q20 caused by low oil prices and regular maintenance. Since SK Biopharm's IPO price of 49,000 KRW is significantly exceeded, it is judged that SK Biopharm will hardly act as an upward momentum for the company's stock price in the future. The stock price is adjusting and moving sideways in the short term due to supply-demand outflows following SK Biopharm's listing. Upside potential will be secured at the next subsidiary IPO." He set SK's target price at 285,000 KRW.


Over the past five days, individual investors have net bought 147,693 shares of SK, while foreigners and institutions have net sold 143,333 shares and 26,362 shares, respectively.



※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing